Direct antiproliferative effect of nonsteroidal 17β-hydroxysteroid dehydrogenase type 1 inhibitors in vitro

References

• Lumachi F, Luisetto G, Basso SM, Basso U, Brunello A, Camozzi V. Endocrine therapy of breast cancer. Curr Med Chem 2011;18:513–522.
   PubMed Web of Science ®Google Scholar
• Miyoshi Y, Ando A, Shiba E, Taguchi T, Tamaki Y, Noguchi S. Involvement of up-regulation of 17β-hydroxysteroid dehydrogenase type 1 in maintenance of intratumoral high estradiol levels in postmenopausal breast cancers. Int J Cancer 2001;94:685–689.
   PubMed Web of Science ®Google Scholar
• Labrie F, Luu-The V, Lin SX, Labrie C, Simard J, Breton R et al. The key role of 17 β-hydroxysteroid dehydrogenases in sex steroid biology. Steroids 1997;62:148–158.
   PubMed Web of Science ®Google Scholar
• Bey E, Marchais-Oberwinkler S, Kruchten P, Frotscher M, Werth R, Oster A et al. Design, synthesis and biological evaluation of bis(hydroxyphenyl) azoles as potent and selective non-steroidal inhibitors of 17β-hydroxysteroid dehydrogenase type 1 (17β-HSD1) for the treatment of estrogen-dependent diseases. Bioorg Med Chem 2008;16:6423–6435.
   PubMed Web of Science ®Google Scholar
• Bey E, Marchais-Oberwinkler S, Werth R, Negri M, Al-Soud YA, Kruchten P et al. Design, synthesis, biological evaluation and pharmacokinetics of bis(hydroxyphenyl) substituted azoles, thiophenes, benzenes, and aza-benzenes as potent and selective nonsteroidal inhibitors of 17β-hydroxysteroid dehydrogenase type 1 (17β-HSD1). J Med Chem 2008;51:6725–6739.
   PubMed Web of Science ®Google Scholar
• Frotscher M, Ziegler E, Marchais-Oberwinkler S, Kruchten P, Neugebauer A, Fetzer L et al. Design, synthesis, and biological evaluation of (hydroxyphenyl)naphthalene and -quinoline derivatives: Potent and selective nonsteroidal inhibitors of 17β-hydroxysteroid dehydrogenase type 1 (17β-HSD1) for the treatment of estrogen-dependent diseases. J Med Chem 2008;51:2158–2169.
   PubMed Web of Science ®Google Scholar
• Marchais-Oberwinkler S, Frotscher M, Ziegler E, Werth R, Kruchten P, Messinger J et al. Structure-activity study in the class of 6-(3′-hydroxyphenyl)naphthalenes leading to an optimization of a pharmacophore model for 17β-hydroxysteroid dehydrogenase type 1 (17β-HSD1) inhibitors. Mol Cell Endocrinol 2009;301:205–211.
   PubMed Web of Science ®Google Scholar
• Marchais-Oberwinkler S, Henn C, Möller G, Klein T, Negri M, Oster A et al. 17ß-Hydroxysteroid dehydrogenases (17ß-HSDs) as therapeutic targets: Protein structures, functions, and recent progress in inhibitor development. J Steroid Biochem Mol Biol 2011;125:66–82.
   PubMed Web of Science ®Google Scholar
• Marchais-Oberwinkler S, Kruchten P, Frotscher M, Ziegler E, Neugebauer A, Bhoga U et al. Substituted 6-phenyl-2-naphthols. Potent and selective nonsteroidal inhibitors of 17β-hydroxysteroid dehydrogenase type 1 (17β-HSD1): Design, synthesis, biological evaluation, and pharmacokinetics. J Med Chem 2008;51:4685–4698.
   PubMed Web of Science ®Google Scholar
• Oster A, Klein T, Werth R, Kruchten P, Bey E, Negri M et al. Novel estrone mimetics with high 17β-HSD1 inhibitory activity. Bioorg Med Chem 2010;18:3494–3505.
   PubMed Web of Science ®Google Scholar
• Bravo L. Polyphenols: Chemistry, dietary sources, metabolism, and nutritional significance. Nutr Rev 1998;56:317–333.
   PubMed Web of Science ®Google Scholar
• Bey E, Marchais-Oberwinkler S, Negri M, Kruchten P, Oster A, Klein T et al. New insights into the SAR and binding modes of bis(hydroxyphenyl)thiophenes and -benzenes: Influence of additional substituents on 17β-hydroxysteroid dehydrogenase type 1 (17β-HSD1) inhibitory activity and selectivity. J Med Chem 2009;52:6724–6743.
   PubMed Web of Science ®Google Scholar
• Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55–63.
   PubMed Web of Science ®Google Scholar
• Vermes I, Haanen C, Reutelingsperger C. Flow cytometry of apoptotic cell death. J Immunol Methods 2000;243:167–190.
   PubMed Web of Science ®Google Scholar
• Minorics R, Szekeres T, Krupitza G, Saiko P, Giessrigl B, Wölfling J et al. Antiproliferative effects of some novel synthetic solanidine analogs on HL-60 human leukemia cells in vitro. Steroids 2011;76:156–162.
   PubMed Web of Science ®Google Scholar
• Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156–159.
   PubMed Web of Science ®Google Scholar
• Gao Q, Tan J, Ma P, Ge J, Liu Y, Sun X et al. PKC α affects cell cycle progression and proliferation in human RPE cells through the downregulation of p27kip1. Mol Vis 2009;15:2683–2695.
   PubMed Web of Science ®Google Scholar
• Matsuhashi N, Saio M, Matsuo A, Sugiyama Y, Saji S. Expression of p53 protein as a predictor of the response to 5-fluorouracil and cisplatin chemotherapy in human gastrointestinal cancer cell lines evaluated with apoptosis by use of thin layer collagen gel. Int J Oncol 2004;24:807–813.
   PubMed Web of Science ®Google Scholar
• Nagasaki S, Miki Y, Akahira J, Suzuki T, Sasano H. 17β-hydroxysteroid dehydrogenases in human breast cancer. Ann N Y Acad Sci 2009;1155:25–32.
   PubMed Web of Science ®Google Scholar
• Husen B, Huhtinen K, Saloniemi T, Messinger J, Thole HH, Poutanen M. Human hydroxysteroid (17-β) dehydrogenase 1 expression enhances estrogen sensitivity of MCF-7 breast cancer cell xenografts. Endocrinology 2006;147:5333–5339.
   PubMed Web of Science ®Google Scholar
• Cook KL, Shajahan AN, Clarke R. Autophagy and endocrine resistance in breast cancer. Expert Rev Anticancer Ther 2011;11:1283–1294.
   PubMed Web of Science ®Google Scholar
• Araújo JR, Gonçalves P, Martel F. Chemopreventive effect of dietary polyphenols in colorectal cancer cell lines. Nutr Res 2011;31:77–87.
   PubMed Web of Science ®Google Scholar
• Rossi M, Bosetti C, Negri E, Lagiou P, La Vecchia C. Flavonoids, proanthocyanidins, and cancer risk: A network of case-control studies from Italy. Nutr Cancer 2010;62:871–877.
   PubMed Web of Science ®Google Scholar
• Thompson DA, Weigel RJ. Characterization of a gene that is inversely correlated with estrogen receptor expression (ICERE-1) in breast carcinomas. Eur J Biochem 1998;252:169–177.
   PubMedGoogle Scholar
• Ercoli A, Battaglia A, Raspaglio G, Fattorossi A, Alimonti A, Petrucci F et al. Activity of cisplatin and ICI 182,780 on estrogen receptor negative ovarian cancer cells: Cell cycle and cell replication rate perturbation, chromatin texture alteration and apoptosis induction. Int J Cancer 2000;85:98–103.
   PubMed Web of Science ®Google Scholar
• Fournier MA, Poirier D. Estrogen formation in endometrial and cervix cancer cell lines: Involvement of aromatase, steroid sulfatase and 17β-hydroxysteroid dehydrogenases (types 1, 5, 7 and 12). Mol Cell Endocrinol 2009;301:142–145.
   PubMed Web of Science ®Google Scholar
• Smuc T, Rizner TL. Expression of 17β-hydroxysteroid dehydrogenases and other estrogen-metabolizing enzymes in different cancer cell lines. Chem Biol Interact 2009;178:228–233.
   PubMed Web of Science ®Google Scholar
• Speirs V, Jenkins S, White MC. Growth factor regulation of 17 β-hydroxysteroid dehydrogenase activity in a human ovarian cell line: Modulation by 17 β-estradiol. Anticancer Res 1993;13:1399–1403.
   PubMed Web of Science ®Google Scholar
• Tolomeo M, Simoni D. Drug resistance and apoptosis in cancer treatment: Development of new apoptosis-inducing agents active in drug resistant malignancies. Curr Med Chem Anticancer Agents 2002;2:387–401.
   PubMedGoogle Scholar
• Kepp O, Galluzzi L, Lipinski M, Yuan J, Kroemer G. Cell death assays for drug discovery. Nat Rev Drug Discov 2011;10:221–237.
   PubMed Web of Science ®Google Scholar
• Sunley K, Butler M. Strategies for the enhancement of recombinant protein production from mammalian cells by growth arrest. Biotechnol Adv 2010;28:385–394.
   PubMed Web of Science ®Google Scholar
• Cheok CF, Verma CS, Baselga J, Lane DP. Translating p53 into the clinic. Nat Rev Clin Oncol 2011;8:25–37.
   PubMed Web of Science ®Google Scholar
• Banerjee S, Li Y, Wang Z, Sarkar FH. Multi-targeted therapy of cancer by genistein. Cancer Lett 2008;269:226–242.
   PubMed Web of Science ®Google Scholar
• Shimizu M, Weinstein IB. Modulation of signal transduction by tea catechins and related phytochemicals. Mutat Res 2005;591:147–160.
   PubMed Web of Science ®Google Scholar
• Sakac M, Gakovic A, Stojanovic S, Djurendic E, Kojic V, Bogdanovic G et al. Synthesis and biological evaluation of a series of A,B-ring modified 16,17-secoandrostane derivatives. Bioorg Chem 2008;36:128–132.
   PubMed Web of Science ®Google Scholar